Klebsiella pneumoniae is an important cause of healthcare-associated infections worldwide. Selective pressure, the extensive use of antibiotics, and the conjugational transmission of antibiotic resistance genes across bacterial species and genera facilitate the emergence of multidrug-resistant (MDR) K. pneumoniae. Here, we examined the occurrence, phenotypes and genetic features of MDR K. pneumoniae isolated from patients in intensive care units (ICUs) at the First Affiliated Hospital of Xiamen University in Xiamen, China, from January to December 2011. Thirty-eight MDR K. pneumoniae strains were collected. These MDR K. pneumoniae isolates possessed at least seven antibiotic resistance determinants, which contribute to the high-level resistance of these bacteria to aminoglycosides, macrolides, quinolones and b-lactams. Among these isolates, 24 strains were extended-spectrum b-lactamase (ESBL) producers, 2 strains were AmpC producers, and 12 strains were both ESBL and AmpC producers. The 38 MDR isolates also contained class I (28/38) and class II integrons (10/38). All 28 class I-positive isolates contained aacC1, aacC4, orfX, orfX' and aadA1 genes. b-lactam resistance was conferred through bla SHV (22/38), bla TEM (10/38), and bla CTX-M (7/38). The highly conserved bla KPC-2 (37/38) and bla (1/38) alleles were responsible for carbapenem resistance, and a gyrA site mutation (27/38) and the plasmid-mediated qnrB gene (13/38) were responsible for quinolone resistance. Repetitive-sequence-based PCR (REP-PCR) fingerprinting of these MDR strains revealed the presence of five groups and sixteen patterns. The MDR strains from unrelated groups showed different drug resistance patterns; however, some homologous strains also showed different drug resistance profiles. Therefore, REP-PCR-based analyses can provide information to evaluate the epidemic status of nosocomial infection caused by MDR K. pneumoniae; however, this test lacks the power to discriminate some isolates. Thus, we propose that both genotyping and REP-PCR typing should be used to distinguish genetic groups beyond the species level.
Introduction
Klebsiella pneumoniae has been medically recognized as one of the most important opportunistic pathogens, causing hospital-acquired and healthcare-associated pulmonary system, urinary tract, circulating system and soft tissue infections worldwide (Podschun and Ullmann, 1998) . However, K. pneumoniae has become a clinically important micro-organism, particularly in last two decades pneumoniae-induced pneumonia in elderly people was 15% to 40%, equal to or even greater than that of Haemophilus influenzae (Molton et al., 2013) . The production of extended-spectrum b-lactamases (ESBL) in this organism contributes to the emergence and dissemination of K. pneumoniae infections. Effective anti-infective drugs, such as aminoglycosides, fluoroquinolones, and carbapenems, have been used to treat ESBL-producing K. pneumoniae infections (Sanchez et al., 2013) . In particular, the use of carbapenems against ESBL-producing Gramnegative micro-organisms poses a serious problem in the management of healthcare-associated infections because the abuse of antibiotics might lead to the emergence of carbapenem-resistant organisms. Notably, the selective pressure posed by the extensive use of antibiotics has facilitated the emergence of multidrug-resistant (MDR) K. pneumoniae. Furthermore, conjugational transmission of antibiotic resistance genes across bacterial species and genera has aggravated the problem of K. pneumoniae antibiotic resistance.
MDR K. pneumoniae was first reported in the United States, followed by Europe, South America, and Asia (Ko et al., 2002; Pfaller et al., 2001; Winokur et al., 2001; Yigit et al., 2001) . At present, infections caused by MDR K. pneumoniae have become a major problem, as few antibiotics are available, resulting in higher morbidity, longer hospitalization, increased mortality rates, and excessive health care costs compared with infections associated with antibiotic-susceptible micro-organisms (Correa et al., 2013; Ma and Wang, 2013) . However, the prevalence of antibioticresistant bacteria significantly varies according to region, country, and susceptible population, as the seriousness of this problem is significantly associated with the measures applied to control the spread of drug-resistant bacteria (Ko et al., 2002) . The aim of this study was to characterize the drug resistance phenotypes and molecular antibiotic resistance mechanisms of MDR K. pneumoniae strains isolated from patients in intensive care units (ICUs). The relatedness of the strains was also investigated using the repetitive-sequence-based PCR (REP-PCR)-based DiversiLab system.
Materials and Methods
Bacterial identification and antimicrobial susceptibility testing A total of 38 MDR K. pneumoniae strains were isolated from sputum, bronchial-alveolar perfusate, blood, intraperitoneal drainage, pleural drainage of patients and surfaces of objects (respirators, bedrails and bedclothes) in ICUs from January to December 2011. Thirty nosocomial infection strains were identified according to the Diagnostic Criteria for Nosocomial Infection established by the Ministry of Health of China. Five strains (K33, K34, K35, K36 and K37) were isolated from ventilators, two strains (K19 and K20) were isolated from bedrails, and one (K31) strain was isolated from bedclothes. Bacterial identification and antimicrobial susceptibility testing were performed using the Vitek2 semi-automated system with GN13 and AST13 cards (bioMérieux Inc., Durham, NC), respectively. The minimum inhibitory concentrations (MICs) for 28 antimicrobial agents for MDR isolates were confirmed using the broth microdilution method. In addition, polymyxin B and tigecycline susceptibilities were determined through Etests (bioMérieux Inc., Durham, NC). Multidrug resistance was defined as non-susceptibility to at least one agent in three or more antimicrobial categories according to the breakpoints recommended by the Clinical and Laboratory Standards Institute (CLSI), excluding tigecycline and polymyxin B. For these studies, K. pneumoniae ATCC 700603 and Pseudomonas aeruginosa ATCC 27853 were used as controls. Disks of cefotaxime (30 mg), cefotaxime/clavulanic acid (30/10 mg), ceftazidime (30 mg), and ceftazidime/clavulanic acid (30/10 mg) were used to confirm ESBL production of these K. pneumoniae isolates using the Double Disc Synergy Test (DDST) according to the recommendations of the CLSI. For the phenotypic identification of AmpC-producing isolates, the DDST was applied using disks containing ceftazidime (30 mg) and ceftazidime/3-aminophenylboronic acid (30/300 mg). A ³ 5-mm enhancement of the zone of inhibition around the ceftazidime disk was considered AmpC-positive. The three-dimensional test was also used to confirm AmpC-producing isolates.
DNA extraction
Genomic DNA from MDR strains was prepared for PCR and genetic analysis using the UltraClean® Microbial DNA Isolation Kit (MO BIO Labs Inc., Solana Beach, CA) according to the manufacturer's instructions. Briefly, MDR strains were grown to the desired optical density and were collected after centrifugation at 10,000 x g for 60 s. The bacterial cells were resuspended in bead solution and transferred to a bead-beating tube containing microbeads and proteinase K. Subsequently, the cells were lysed through mechanical disruption using a specially designed MO BIO Vortex Adapter on a standard vortex. The supernatant was loaded onto a Spin Filter mini column and washed twice with Wash buffer, and the genomic DNA was eluted with DNA-free Tris buffer.
Resistance determinants detection
The genes involved in the antibiotic resistance of MDR strains were screened through PCR assays as previously described (Perez-Perez and Hanson, 2002; Wen, 2010; Mak, 2009) , except that the PCR conditions used to detect bla KPC and bla NDM-1 , included a pre-denaturing step at 94°C for 5 min, followed by 30 cycles at 94°C for 30 s, 55°C for 30 s, and 72°C for 60 s, with polishing at 72°C for 10 min. The PCR products were purified using the QIAGEN Gel Extraction Kit (Qiagen Inc., Hilden, Germany) and were subjected to sequencing using the same primers used for PCR amplification. The resistance genes and the primers used in the present study are listed in Table 1 .
Genetic relatedness determination
The genetic similarities of the MDR K. pneumoniae strains were further analyzed using REP-PCR, a semiautomated PCR technique for the amplification of the regions between the non-coding repetitive sequences in bacterial genomes. REP-PCR was performed using the DiversiLab Klebsiella Kit (bioMérieux Inc., Durham, NC) according to the manufacturer's instructions. The PCR products were separated on an Agilent B2100 Bioanalyzer using DNA LabChip reagents (Agilent Technologies Inc., Palo Alto, CA). The data were uploaded to the web-based DiversiLab system for further analysis. All results, including dendrograms, scatterplots, electropherograms, and virtual gel images, were illustrated using DiversiLab software MDR K. pneumoniae 761 (Wen and Mi, 2010) TEM-R GAAGCTAGAGTAAGTAGTTCG bla TEM (Wen and Mi, 2010) SHV-F ACCTTTAAAGTAGTGCTCTGC bla SHV (Wen and Mi, 2010) SHV-R CACCATCCACTGCAGCAGCTG bla SHV (Wen and Mi, 2010) CTX-M-F ATGGTTAAAAAATCACTGCGYCAGTTC bla CTX-M (Wen and Mi, 2010) CTX-M-R TCACAAACCGTYGGTGACGATTTTAGCCGC bla CTX-M (Wen and Mi, 2010) OXA-F CTGTTGTTTGGGTTTCGCAAG bla OXA (Wen and Mi, 2010) OXA-R CTTGGCTTTTATGCTTGATG bla OXA (Wen and Mi, 2010) PER-F GCCTGACGATCTGGAACC bla PER (Wen and Mi, 2010) PER-R GATACTGCACCTGATCATC bla PER (Wen and Mi, 2010) VEB-F GCGTTATGAAATTTCCGATTG bla VEB (Wen and Mi, 2010) VEB-R CAACATCATTAGTGGCTGCTG bla VEB (Wen and Mi, 2010) GES-F ATGCGCTTCATTCACGCAC bla GES (Wen and Mi, 2010) GES-R CTATTTGTCCGTGCTCAGG bla GES (Wen and Mi, 2010) 1Int-F ATCATCGTCGTAGAGACGTCGG Class I Integron (Wen and Mi, 2010) 1Int-R GTCAAGGTTCTGGACCAGTTGC Class I Integron (Wen and Mi, 2010) 2Int-F GCAAATAAAGTGCAACGC Class II Integron (Wen and Mi, 2010) 2Int-R ACACGCTTGCTAACGATG Class II Integron (Wen and Mi, 2010) (v.r.3.3.40). Pearson's correlation coefficient and the unweighted-pair group method were used to determine the genetic similarity of the tested isolates. Strains with similarities > 98% are indistinguishable and designated as one pattern, and strains with similarities between 95% and 98% are homologous and designated as one group (Tenover, 2009; Marchaim, 2011) .
Results

In vitro antimicrobial susceptibility
All 38 MDR K. pneumoniae strains showed resistance to aminoglycosides, macrolides, quinolones and blactams in the semi-automated systems. All isolates yielded MIC values ³ 128 mg/L for cefotaxime and ceftazidime; ³ 8 mg/L for imipenem, ertapenem and meropenem; ³ 128 mg/L for kanamycin and amikacin; and ³ 16 mg/L for ciprofloxacin. All MDR isolates were susceptible to colistin (£ 1 mg/L), tigecycline (£ 1 mg/L) and fosfomycin (£ 64 mg/L). Among the 38 MDR K. pneumoniae isolates, 89.5% (34/38) were confirmed as ESBL producers, while 36.8% (14/38) were AmpC producers, and 31.5% (12/38) produced both ESBL and AmpC b-lactamases. The susceptibility characteristics of the MDR K. pneumoniae are shown in Tables 2 and 3 .
Detection and characterization of integrons
PCR was used to assess the presence of integrons in the MDR K. pneumoniae strains as previously described (Mak, 2009 ). Class I and II integrons were detected in 73.7% (28/38) and 26.3% (10/38) of the strains, respectively. No class III integrons were detected. Subsequent PCR amplification and sequencing revealed that all 28 class I integron-positive K. pneumoniae isolates contained aacC1, which confers a high level of gentamicin resistance, aacC4, which encodes amikacin and tobramycin resistance, aadA1, which confers spectinomycin and streptomycin resistance, and two unknown open reading frames, orfX and orfX'.
Aminoglycoside resistance
All 38 MDR isolates were resistant to streptomycin, while only 28 class I integron-positive isolates contained aadA1, aacC1 and aacC4. Therefore, the other two streptomycin resistance genes, strA and strB, were screened through PCR. Eight class II integron-positive K. pneumoniae isolates containing the strB gene were detected, whereas no isolates containing the strA gene were observed. The control strain K. pneumoniae ATCC 700603 was completely sensitive to both spectinomycin and streptomycin; this strain also lacked aadA1, strA and strB genes.
Genetic basis of b-lactam resistance
The PCR analyses demonstrated that ESBL-producing MDR K. pneumoniae strains were rich in b-lactamase genes, such as bla SHV (22/38), bla TEM (10/38) and bla CTX-M (7/38) ( Table 3) . Non-ESBL producers also harbored at least one b-lactamase gene. bla and bla CTX-M-9 genes were highly prevalent, accounting for 42% and 13%, respectively, of class A b-lactamase genes, while bla CTX-M-1 was not detected. Quinolone resistance is conferred through a gyrA site mutation or the qnrB gene
All 38 MDR isolates showed resistance to norfloxacin (MIC ³ 256 mg/L) and ciprofloxacin (MIC ³ 16 mg/L). To identify the quinolone resistance determinants, three subtypes of qnr genes (qnrA, qnrB, and qnrS) and two subtypes of gyr genes (gyrA and gyrB) were screened through PCR and sequencing analyses. Among the 38 MDR K. pneumoniae isolates, 13 isolates contained the plasmid-mediated quinolone resistance determinant qnrB, and 27 isolates contained the DNA gyrase gene gyrA, containing a nucleotide mutation in the quinolone-resistance determining region (QRDR). This mutation results in an amino acid change of S83L, which confers quinolone resistance in many bacteria. The gene qnrB was present in isolates that did not contain the gyrA mutation, and high rates of the qnrB4 subtype were detected among qnrB-positive isolates (10/12). The plasmid-mediated qnrB gene was also detected among 27 gyrA mutation strains of the two isolates K38 and K2. The qnrS gene was not detected in any of the MDR K. pneumoniae strains. The control strain K. pneumoniae ATCC 700603, which did not carry the gyrA mutation or any qnr gene, was susceptible to quinolones. These findings suggest that the S83L gyrA site mutation conferred quinolone resistance to 27 of 38 isolates, and qnrB conferred quinolone resistance to the other 11 isolates. qnrA, qnrS and mutations in gyrB were not detected in any of the 38 MDR K. pneumoniae isolates.
REP-PCR and genetic diversity
To characterize the genetic diversity of the 38 MDR K. pneumoniae isolates with similar multidrug resistance profiles, strain typing based on REP-PCR was performed using genomic DNA. Five REP-PCR groups and sixteen patterns were observed (Figure 1) . K7, K9, K22, K24, K1, K11, K17, K19, K16, K15, K13, and K31 showed high similarity (> 95%) in group II, designating the type 3 REP-PCR pattern. Moreover, the strains in group II pattern III, except for K19 (isolated from a bedrail) and K33 (isolated from bedclothes), were isolated from ICU patients. All group II strains, except K11 and K2, possessed class I integrons and aphA. Therefore, REP-PCR lacked the power to discriminate MDR K. pneumoniae strains, suggesting that a combination of genotypic data and REP-PCR types should be used to group the 38 isolates.
Discussion
The incidence of MDR K. pneumoniae infections has increased during the last decade, reflecting the extensive use of antimicrobial agents (Wu et al., 2012) . MDR K. pneumoniae is considered as a significant health problem because of limited options for antibiotic treatment. In this study, we conducted the phenotypic characterization and investigated the molecular mechanisms of antibiotic resistance for MDR K. pneumoniae strains isolated from ICUs. REP-PCR-based homology analyses provide information concerning the epidemic status of nosocomial infections caused by MDR K. pneumoniae.
In this study, 89.5% of the MDR K. pneumoniae strains isolated from ICU patients during a 12-month period were ESBL producers. This percentage was much higher than those reported in previous studies concerning other types of bacteria in China (Huang et al., 2007; Wang et al., 2012; Yong-Hong, 2012; Chen et al., 2012) . The ESBL-positive MDR K. pneumoniae strains possessed at least seven resistance determinants conferring resistance phenotypes to nine classes of antimicrobials. This finding was troubling, as most clinical therapeutic regimens are restricted to a maximum of 4 classes. No significant associations among ESBL-producing strains, antibiotic susceptibilities and integron carriage profiles were observed. However, isolates with similar resistance determinant profiles showed similar antibiotic resistance phenotypes. Notably, class I integrons were predominantly detected among ESBL-positive K. pneumoniae isolates (82.4%), consistent with the results of previous Asian studies. However, this percentage is slightly higher than those reported in Australian and American studies and much higher than those reported in European studies (Wu et al., 2012; Rao et al., 2006; Yao et al., 2007; Machado et al., 2007; Jiang et al., 2012) . According to the results obtained in the present study, 26.3% of the MDR K. pneumoniae isolates and 15.7% of the ESBL-producing isolates harbored class II integrons. Several studies have also reported the distribution of class II integrons among the Enterobacteriaceae family, including Escherichia coli, Salmonella and Enterobacter cloacae, and Acinetobacter baumannii in China (Zhou et al., 2013; Gu et al., 2006; Li et al., 2008) . The co-existence of class I and II integrons was not observed in any of the MDR K. pneumoniae strains. To our knowledge, there has only one report describing the coexistence of class I and II integrons among Enterobacteriaceae in China (Li et al., 2008) .
The prevalence and wide distribution of plasmidmediated quinolone resistance determinants has been demonstrated among clinical isolates in China. In the present study, plasmid-mediated quinolone resistance determi- (Table 3) . Previous studies have also shown that most ESBL genes are located in transposons and self-transferable plasmids, which typically co-exist with plasmidmediated quinolone resistance determinants (Jiang et al., 2012; Hassan et al., 2012; Park et al., 2012; Han et al., 2010) . This phenotype might reflect the excessive use of cephalosporins and quinolones and the absence of strict antimicrobial policies in medical care facilities. The most frequent ESBL genotype among the qnr-positive K. pneumoniae strains was SHV-12, a result that was not consistent with results showing that SHV-7 was more common in qnr-positive isolates (Jiang et al., 2012) . Carbapenems have been considered as last resort treatments against infections caused by MDR Gram-negative organisms. However, Klebsiella has developed an efficient carbapenem resistance mechanism, known as KPC (Klebsiella pneumoniae carbapenemase) . In China, KPC-producing K. pneumoniae was first identified in 2007 (Leavitt et al., 2007; Cuzon et al., 2008) . Since then, the prevalence of KPC-producing K. pneumoniae has increased to epidemic proportions, particularly in large and public city hospitals. An increase in carbapenem-resistant strains has recently been reported in China (Cai et al., 2008) , likely reflecting the horizontal and vertical transmission of KPC-encoding genes, overcrowded environments and insufficient infection control measures in these hospitals. In the present study, sequencing and alignment revealed the presence of the bla KPC-2 allele in 37 MDR K. pneumoniae isolates. The bla KPC-2 genes amplified from these isolates were highly conserved, and no nucleotide differences were observed. However, the KPC-negative isolate was also OXA-23-positive. To our knowledge, few studies have revealed the contribution of bla to carbapenem resistance in other bacteria, with the exception of Acinetobacter baumannii. Because the bla OXA-23 gene identified in the KPC-negative K. pneumoniae isolate showed 100% identity to Acinetobacter baumannii bla (data not shown), we speculated that bla OXA-23 was transferred from A. baumannii through mobile genetic elements, which have been implicated in the dissemination of antimicrobial resistance through horizontal transmission. Previous studies have shown that integrons contribute to the prevalence of transferable extended-spectrum cephalosporin resistance through Enterobacteriaceae (Pisney et al., 2013; Magiorakos et al., 2013) . Therefore, an in-depth investigation is required to study the mechanism of reduced susceptibility and to predict the clinical efficiency of carbapenem drugs.
The results of the present study demonstrated that the streptomycin resistance of class I integron-positive K. pneumoniae isolates was conferred through the aadA1 gene cassette. However, the widespread streptomycin resistance gene strB was only detected in class II integron-positive isolates. So far, the genes strA and strB are considered as a gene pair, comprising a mobile genetic element of the conjugative antibiotic resistance plasmid, which confers high-level streptomycin resistance in bacteria (Chiou et al., 1995; Tauch et al., 2003) . We did not detect the strA gene in any of the isolates examined; thus, it is likely that the strB gene is an element of class II integrons. Currently, we are examining the genetic elements of class II integrons and the mechanism of streptomycin resistance in two other class II integron-positive strains, which have been demonstrated as strB-negative.
To provide evidence for the prevention and control of nosocomial infections, the genotypic similarities of MDR K. pneumoniae strains were investigated using the REP-PCR-based DiversiLab system. Five different groups and sixteen patterns of MDR K. pneumoniae were isolated from ICU patients. The MDR K. pneumoniae isolated from the ventilators and bed rails shared genetic similarities with the strains isolated from patients. The homology between some strains isolated from ventilators and bedrails suggested that the equipment or object surfaces in the ICU had persistent MDR K. pneumoniae colonization. Although REP-PCR is a powerful tool for strain typing, with resolution beyond the species level, this technique lacked the power to discriminate group II strains, as all of the MDR strains in group II, except K11 and K2, possessed class I integrons and aphA. Furthermore, the K. pneumoniae strains in the same clone group could possess different resistance phenotypes and different drug resistance determinants. Therefore, REP-PCR fingerprinting should be combined with other detection methods to distinguish genetic groups beyond the species level.
In conclusion, MDR K. pneumoniae is becoming a serious problem in ICUs, with many strains developing resistance to most available antibiotics. The results of this study provide evidence for appropriate surveillance and outbreak investigations. We propose that infection control measures and strict antimicrobial stewardship policies should be applied to reduce the selective pressure that inevitably favors the emergence and epidemic of MDR strains and to increase the therapeutic usefulness of these antibiotics.
